The EPS projection of Procter & Gamble Co (NYSE:PG) for quarter ended 2016-09-30 is $1. A week before, the EPS forecast was $1 against target of $1, a month earlier. This estimate stood at $1 60 days earlier versus forecast of $1 90 days earlier, confirming a deviation of 0%.
Procter & Gamble Co (NYSE:PG) reported that 18 days ago, the positive EPS revisions were 0 and negative revisions at 3.
In last week, the per-share earnings was lowered 0 times and 0 times positively. In last 120, 60, 30 and 90 days the positive revisions were 0, 0, 0 and 0, respectively.
The downgrade of EPS estimates for Procter & Gamble Co (NYSE:PG) in the preceding 120, 60, 30 and 90 days were 4, 5, 0 and 4, in that order.
As per the latest update, for the quarter closed 3, the EPS estimate of Procter & Gamble Co (NYSE:PG) was $1. This projection was computed after accounting 10 calls. As reported on 2016-04-26 the EPS was $0.86. The change was $0.05, demonstrating a percentage deviation of 6.17%. The projections confirmed a standard deviation of 0.02.
Quarterly Sales Estimates
For the fiscal 2017, the yearly sales target for Procter & Gamble Co (NYSE:PG) stands at $16241.525 and the median estimate at $16245.05. Almost 4 analysts announced their estimates.
The highest estimate is $16381 while the lowest target is $16095 showing standard deviation of 153.029%.
As many as 4 analysts released sales estimates reised in upside while 4 reduced sales estimates, demonstrating a deviation of 0%.
In last month, 4 revised sales number projection on upside while 4 lowered the sales target, demonstrating a deviation of 0%.
A quarter ago, 4 hiked sales estimations and 4 reduced sales forecast. Procter & Gamble Co (NYSE:PG) stated that the change in forecast was 0.619%.
1 Chart Pattern Every Investor Should Know
This little-known pattern preceded moves of 578% in ARWR, 562% in LCI, 513% in ICPT, 439% in EGRX, 408% in ADDUS and more...